UBS Group »

Akari Therapeutics Plc Sponsored shares owned by UBS Group

Quarter-by-quarter ownership of Akari Therapeutics Plc Sponsored (AKTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Akari Therapeutics Plc Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics Plc Sponsored held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics Plc Sponsored by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $61 60 1.02
2025-06-30 $2.5k 2.2k 1.17
2024-12-31 $236 194 1.22
2024-06-30 $43k 16k 2.70

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Akari Therapeutics Plc Sponsored

Cresset Asset Management
Palo Alto Investors
HighTower Advisors
Omnia Family Wealth
HPM Partners
Virtu Financial
Two Sigma Securities
Independent Advisor Alliance
Accent Capital Management
Goss Wealth Management
UBS Group
Truvestments Capital
EverSource Wealth Advisors
Cornerstone Planning Group
Morgan Stanley

View all funds holding Akari Therapeutics Plc Sponsored